Skip to content

stocks and commodities

Novo Nordisk

NVO · records on this site: 1.

Parts of this page are in Russian: the English text is not available yet.

News

13 November 2026, 04:01 MSK Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug

This page as data